Cefepime-tazobactam: A promising therapeutic option

被引：0
|
作者：
Panchatcharam, S. N. [1 ]
Ramasubramanian, V. [1 ]
Gopalakrishnan, R. [1 ]
Ghafur, A. [1 ]
Thirunarayan, M. [1 ]
机构：
[1] Apollo Hosp, Madras 600006, Tamil Nadu, India
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2012年 / 16卷
关键词：
D O I：
10.1016/j.ijid.2012.05.681
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E470 / E471
页数：2
相关论文
共 50 条
  • [1] Clinical efficacy and safety of cefepime-tazobactam in hospitalized patients in South India
    Bansal, Nitin
    Sukhwani, Kalpesh S.
    Kumar, Suresh D.
    Nambi, P. Senthur
    Gopalakrishnan, Ram
    Ramasubramanian, V.
    INFECTIOUS DISEASES, 2018, 50 (05) : 391 - 394
  • [2] Antimicrobial activity of cefepime-tazobactam combination tested against clinical isolates of Enterobacteriaceae
    Kaur, Ramanpreet
    Gautam, Vikas
    Singhal, Lipika
    Ray, Pallab
    JOURNAL OF ANTIBIOTICS, 2014, 67 (08): : 603 - 604
  • [3] Single-Center Investigation of the Pharmacokinetics of WCK 4282 (Cefepime-Tazobactam Combination) in Renal Impairment
    Preston, Richard A.
    Mamikonyan, Grigor
    Mastim, Mushtaque
    Garg, Dyal
    Kemper, Christopher J.
    Xu, Allan
    Yeole, Ravindra
    Chavan, Rajesh
    Friedland, H. David
    Bhatia, Ashima
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [4] P081: Cefepime-tazobactam: a new antibiotic against ESBL producing enterobacteriaceae in cancer patients
    S Biswas
    R Kelkar
    Antimicrobial Resistance and Infection Control, 2 (Suppl 1)
  • [5] Secukinumab: a promising therapeutic option in spondyloarthritis
    Hernan Maldonado-Ficco
    Rodolfo Perez-Alamino
    José A. Maldonado-Cocco
    Clinical Rheumatology, 2016, 35 : 2151 - 2161
  • [6] Secukinumab: a promising therapeutic option in spondyloarthritis
    Maldonado-Ficco, Hernan
    Perez-Alamino, Rodolfo
    Maldonado-Cocco, Jose A.
    CLINICAL RHEUMATOLOGY, 2016, 35 (09) : 2151 - 2161
  • [7] DMF: a promising therapeutic option in CTCL
    Vancurova, Ivana
    BLOOD, 2016, 128 (06) : 745 - 746
  • [8] Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014
    Sader, Helio S.
    Castanheira, Mariana
    Mendes, Rodrigo E.
    Flamm, Robert K.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (04)
  • [9] Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chloride
    Castanheira, Mariana
    Duncan, Leonard R.
    Rhomberg, Paul R.
    Sader, Helio S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (04) : 305 - 309
  • [10] Ulcerative colitis: Ozanimod a promising Therapeutic Option
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (05) : 221 - 222
12345